Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

29.13
-0.1900-0.65%
Post-market: 29.01-0.1217-0.42%19:56 EDT
Volume:3.90M
Turnover:115.25M
Market Cap:21.63B
PE:-85.79
High:30.98
Open:29.05
Low:28.61
Close:29.32
Loading ...

Expert says Summit’s HARMONi-2 study could beat expectations, says Truist

TIPRANKS
·
11 Apr

Summit Therapeutics (SMMT) Gets a Buy from Truist Financial

TIPRANKS
·
10 Apr

We Think Summit Therapeutics (NASDAQ:SMMT) Can Easily Afford To Drive Business Growth

Simply Wall St.
·
05 Apr

U.K. New-Car Sales Rose in March as EV Registrations Surged, Industry Body SMMT Says

Dow Jones
·
04 Apr

Esperion Therapeutics (ESPR) Down 15.8% Since Last Earnings Report: Can It Rebound?

Zacks
·
03 Apr

Why Is Corcept (CORT) Down 5.3% Since Last Earnings Report?

Zacks
·
28 Mar

UK car output dips as Trump auto tariffs loom

cityam
·
27 Mar

U.K., U.S. Auto Industries Need to Strike Mutually Beneficial Deal, SMMT Says -- Market Talk

Dow Jones
·
27 Mar

BUZZ-Summit gains as Citigroup raises to 'buy' on cancer drug prospects

Reuters
·
26 Mar

Summit Therapeutics Raised to Buy From Neutral by Citigroup

Dow Jones
·
26 Mar

S&P 500 Futures Decline In Premarket Trading; GameStop, Summit Therapeutics Lead

Dow Jones
·
26 Mar

Citigroup Upgrades Summit Therapeutics to Buy From Neutral, Adjusts Price Target to $35 From $23

MT Newswires Live
·
26 Mar

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
22 Mar

Summit Therapeutics Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
21 Mar

Cantor Fitzgerald Initiates Summit Therapeutics at Overweight

MT Newswires Live
·
21 Mar

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT Newswires Live
·
18 Mar

Summit Therapeutics names Robert LaCaze as Chief Commercial Officer

TIPRANKS
·
18 Mar

Is Summit Therapeutics Inc. (SMMT) the Best Multibagger Stock to Buy in 2025?

Insider Monkey
·
14 Mar

Stifel Nicolaus Keeps Their Buy Rating on Summit Therapeutics (SMMT)

TIPRANKS
·
11 Mar

Summit Therapeutics Inc. (SMMT): Why Are Analysts Bullish On This Hot Growth Stock Right Now?

Insider Monkey
·
09 Mar